Literature DB >> 18851945

Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells.

Yeon Hee Park1, Hae Hyun Jung1, Jin Seok Ahn1, Young-Hyuck Im2.   

Abstract

The human epidermal growth factor receptor-2 (HER2) plays an important role in breast cancer. Enhanced Ets-1 activity has recently been shown to be associated with breast cancer pathogenesis. To test the role of Ets-1 in breast cancer cells in relation to the expression of HER2 and MMP-1, we transiently overexpressed Ets-1 and/or HER2 in MCF-7 breast cancer cells and comprehensively searched for genes related to HER2 and Ets-1 using cDNA microarray analysis. The expression of matrix metalloproteinase (MMP) genes was enhanced by the overexpression of HER2/Ets-1. We analyzed the relationship between HER2-induced MMP-1 expression and the transcription factor Ets-1, which has significant activity in breast cancer pathogenesis. Our results demonstrate that HER2-induced MMP-1 expression is positively regulated by Ets-1 in breast cancer cells. This study confirms that Ets-1 is a downstream effector of oncogenic HER2, associated with MMP-1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18851945     DOI: 10.1016/j.bbrc.2008.09.135

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2011-08-11       Impact factor: 8.775

Review 2.  The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Authors:  Katie Lin; Stavroula Baritaki; Silvia Vivarelli; Luca Falzone; Aurora Scalisi; Massimo Libra; Benjamin Bonavida
Journal:  Antioxidants (Basel)       Date:  2022-06-17

3.  Ets-1 regulates energy metabolism in cancer cells.

Authors:  Meghan L Verschoor; Leigh A Wilson; Chris P Verschoor; Gurmit Singh
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

4.  No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.

Authors:  Alicia Beeghly-Fadiel; Qiuyin Cai; Wei Lu; Jirong Long; Yu-Tang Gao; Xiao-Ou Shu; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

5.  ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis.

Authors:  Wenliang Zhang; Jiawei Zhao; Jen-Fu Lee; Allison Gartung; Hiba Jawadi; Wanyu Louis Lambiv; Kenneth V Honn; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

6.  A new prodrug form of Affibody molecules (pro-Affibody) is selectively activated by cancer-associated proteases.

Authors:  Lisa Sandersjöö; Andreas Jonsson; John Löfblom
Journal:  Cell Mol Life Sci       Date:  2014-10-07       Impact factor: 9.261

7.  A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer.

Authors:  Chiao-Yun Lin; Angel Chao; Tzu-Hao Wang; Swei Hsueh; Yun-Shien Lee; Tzu-I Wu; An-Shine Chao; Huei-Jean Huang; Hung-Hsueh Chou; Ting-Chang Chang; Chyong-Huey Lai
Journal:  J Mol Med (Berl)       Date:  2014-05-14       Impact factor: 4.599

8.  Localization and Molecular Characterization of human Breast Cancer Initiating Cells from heterogeneous population of Breast Cancer Mesenchymal Stem cells by Immunofluorescence Microscopy.

Authors:  P Potdar; F Monteiro
Journal:  J Stem Cells Regen Med       Date:  2012-11-26

9.  When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase.

Authors:  Ditte Marie Brix; Knut Kristoffer Bundgaard Clemmensen; Tuula Kallunki
Journal:  Cells       Date:  2014-01-27       Impact factor: 6.600

10.  Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancers.

Authors:  Meghan L Verschoor; Chris P Verschoor; Gurmit Singh
Journal:  Cancer Metab       Date:  2013-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.